Mannkind (MNKD) Gross Profit Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,488.21% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 10.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.83% |
| Dec 31, 2025 | 36.21% |
| Sep 30, 2025 | 16.07% |
| Jun 30, 2025 | 7.70% |
| Mar 31, 2025 | 19.44% |
| Dec 31, 2024 | -8.16% |
| Sep 30, 2024 | 76.88% |
| Jun 30, 2024 | 92.96% |
| Mar 31, 2024 | 128.60% |
| Dec 31, 2023 | 26.00% |
| Sep 30, 2023 | 96.08% |
| Jun 30, 2023 | 901.69% |
| Mar 31, 2023 | 3,811.41% |
| Dec 31, 2022 | 403.75% |
| Sep 30, 2022 | 4.81% |
| Jun 30, 2022 | -122.88% |
| Mar 31, 2022 | -105.61% |
| Dec 31, 2021 | -238.43% |
| Sep 30, 2021 | 56.44% |
| Jun 30, 2021 | 642.68% |
| Mar 31, 2021 | 8.70% |
| Dec 31, 2020 | 30.19% |
| Sep 30, 2020 | 283.79% |
| Jun 30, 2020 | 15.75% |
| Mar 31, 2020 | -10.11% |
| Dec 31, 2019 | 2.86% |
| Sep 30, 2019 | -667.27% |
| Jun 30, 2019 | -243.34% |
| Mar 31, 2019 | 2,572.93% |
| Dec 31, 2018 | 2,363.32% |
| Sep 30, 2018 | 67.06% |
| Jun 30, 2018 | 58.88% |
| Mar 31, 2018 | -217.79% |
| Dec 31, 2017 | -105.95% |
| Sep 30, 2017 | -101.60% |
| Jun 30, 2017 | 27.74% |
| Mar 31, 2017 | 108.92% |
| Dec 31, 2016 | 116.71% |
| Sep 30, 2016 | 31,255.82% |
| Jun 30, 2016 | 28.92% |
| Mar 31, 2016 | -174.60% |